Risultati della ricerca - Hsing‐Yu Chen
- Mostra 1 - 13 risultati su 13
-
1
Patient Safety and Staff Well-Being: Organizational Culture as a Resource di Luo Lu, Yi-Ming Ko, Hsing‐Yu Chen, Jui-Wen Chueh, Haw‐Wen Chen, Cary L. Cooper
Pubblicazione 2022Artigo -
2
The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clin... di Lin‐Yu Chen, Hsing‐Yu Chen, Hung-Cheng Lai, Shiou‐Fu Lin, Kuo‐Chang Wen, Darmawi Darmawi, Phui‐Ly Liew
Pubblicazione 2025Artigo -
3
<i>Hedyotis diffusa</i> Combined with <i>Scutellaria barbata</i> Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population‐Based Study di Yuan-Chieh Yeh, Hsing‐Yu Chen, Sien‐Hung Yang, Yi‐Hsien Lin, Jen‐Hwey Chiu, Yi‐Hsuan Lin, Jiun-Liang Chen
Pubblicazione 2014Artigo -
4
Drought and Salt Stress Tolerance of an Arabidopsis Glutathione <i>S</i>-Transferase U17 Knockout Mutant Are Attributed to the Combined Effect of Glutathione and Abscisic Acid di Jui‐Hung Chen, Han-Wei Jiang, En‐Jung Hsieh, Hsing‐Yu Chen, Ching‐Te Chien, Hsu-Liang Hsieh, Tsan‐Piao Lin
Pubblicazione 2011Artigo -
5
-
6
-
7
Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study di Hsing‐Yu Chen, Heng-Chih Pan, Yung-Chang Chen, Yu‐Chun Chen, Yi-Hsuan Lin, Sien-Hung Yang, Jiun-Liang Chen, Hau‐Tieng Wu
Pubblicazione 2019Artigo -
8
Involvement of Hypoxia-inducing Factor-1α-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion di Ming–Tsan Lin, I‐Hsin Kuo, Cheng-Chi Chang, Chia‐Yu Chu, Hsing‐Yu Chen, Been‐Ren Lin, Munisamy Sureshbabu, Hou-Jung Shih, Min‐Liang Kuo
Pubblicazione 2008Artigo -
9
-
10
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance di Nobuaki Takahashi, Hsing‐Yu Chen, Isaac S. Harris, Daniel G. Stover, Laura M. Selfors, Roderick T. Bronson, Thomas De Raedt, Karen Cichowski, Alana L. Welm, Yasuo Mori, Gordon B. Mills, Joan S. Brugge
Pubblicazione 2018Artigo -
11
-
12
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response di Ioannis K. Zervantonakis, Claudia Iavarone, Hsing‐Yu Chen, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula A. Matulonis, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge
Pubblicazione 2017Artigo -
13
Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity di Yi‐Hsuan Lin, Helen Luck, Saad Khan, Pierre H. H. Schneeberger, Sue Tsai, Xavier Clemente‐Casares, Helena Lei, Yann‐Lii Leu, Yi Tao Chan, Hsing‐Yu Chen, Sien‐Hung Yang, Bryan Coburn, Shawn Winer, Daniel A. Winer
Pubblicazione 2019Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Biology
Biochemistry
Cancer
Cancer research
Endocrinology
Gene
Cell biology
Genetics
Chemistry
Diabetes mellitus
Disease
Environmental health
Kidney disease
Population
Receptor
Apoptosis
Cancer cell
Cohort
Cohort study
Computer science
Confidence interval
Hazard ratio
Immune system
Immunology
Mutant
Oncology
Ovarian cancer
PI3K/AKT/mTOR pathway